Envoy Medical, Inc. / Fundamental strength relative to industry (Mohanram G-Value)
The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.
- Fundamental strength relative to industry (Mohanram G-Value)
-
1 / 7
- Return on assets (ROA) greater than industry median
- close -214.8% ≤ -214.8%
- Operating cash flow over total assets greater than industry median
- close -155.4% ≤ -155.4%
- Operating cash flow greater than net income
- check -$13.12M > -$18.14M
- Variance in ROA over the last 5 years less than industry median
- close 3,281.8% ≥ 3,281.8%
- Variance in year-over-year sales growth over the last 5 years less than industry median
- close 9.1% ≥ 9.1%
- R&D expenses over total assets greater than industry median
- close 105.7% ≤ 105.7%
- Capex over total assets greater than industry median
- close 0.9% ≤ 0.9%
G-Value history
The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.
-
0
-
0
-
0
-
0
-
1
-
1
-
1
-
1
-
1
-
0
-
0
-
1
-
1
-
1